These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4609736)

  • 1. [Activation of the apathetic mentally retarded by drug therapy].
    Turunen S; Rimón R
    Duodecim; 1974; 90(11):839-42. PubMed ID: 4609736
    [No Abstract]   [Full Text] [Related]  

  • 2. Factors determining patient tenure on a 3-year double-blind investigation of pimozide versus fluphenazine HCl.
    Abuzzahab FS; Zimmermann RL
    Adv Biochem Psychopharmacol; 1980; 24():547-50. PubMed ID: 7405675
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia.
    Falloon I; Watt DC; Shepherd M
    Psychol Med; 1978 Feb; 8(1):59-70. PubMed ID: 345313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medico-social evaluation of the long-term pharmacotherapy of schizophrenia. Comparative study of fluphenazine and pimozide.
    Shepherd M
    Prog Neuropsychopharmacol; 1979; 3(4):383-9. PubMed ID: 401349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
    McCreadie RG; Dingwall JM; Wiles DH; Heykants JJ
    Br J Psychiatry; 1980 Dec; 137():510-7. PubMed ID: 7011468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A three-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia.
    Abuzzahab FS; Zimmermann RL
    Psychopharmacol Bull; 1976 Apr; 12(2):26-7. PubMed ID: 769023
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-acting therapy of schizophrenia.
    Rapisarda V; Bonomo V; Parisi R
    Adv Biochem Psychopharmacol; 1985; 40():25-8. PubMed ID: 4025038
    [No Abstract]   [Full Text] [Related]  

  • 8. Pimozide and the social behavior of schizophrenics.
    Lapierre YD; Lavallee J
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):181-88. PubMed ID: 809233
    [No Abstract]   [Full Text] [Related]  

  • 9. A multicenter multidimensional study of some new longacting neuroleptic drugs.
    Acta Psychiatr Scand Suppl; 1974; 249():1-134. PubMed ID: 4608507
    [No Abstract]   [Full Text] [Related]  

  • 10. Once weekly pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
    McCreadie R; Mackie M; Morrison D; Kidd J
    Br J Psychiatry; 1982 Mar; 140():280-6. PubMed ID: 7093596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinical study of Esucos in a mentally retarded clientele.
    Lindholm O
    Int J Neuropsychiatry; 1967 Jun; 3(3):209-18. PubMed ID: 5340605
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and effectiveness of haloperidol for mentally retarded behaviorally disordered and hyperkinetic patients.
    Grabowski SW
    Curr Ther Res Clin Exp; 1973 Nov; 15(11):856-61. PubMed ID: 4201599
    [No Abstract]   [Full Text] [Related]  

  • 13. The social outcome of patients in a trial of long-term continuation therapy in schizophrenia: pimozide vs. fluphenazine.
    Falloon I; Watt DC; Shepherd M
    Psychol Med; 1978 May; 8(2):265-74. PubMed ID: 418431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study of the use and therapeutic activity of oenanthate of fluphenazine, a neuroleptic with long-term action, in psychoses in children].
    Michaux L; Dugas M; Colomb G; Guériot C
    Rev Neuropsychiatr Infant; 1971 Jun; 19(6):351-9. PubMed ID: 5564560
    [No Abstract]   [Full Text] [Related]  

  • 15. [Experience in the management of chronic psychoses using fluphenazine-oenanthate].
    Eichstetter F
    Nervenarzt; 1968 Jun; 39(6):282-3. PubMed ID: 5712435
    [No Abstract]   [Full Text] [Related]  

  • 16. A series of multicentric pilot trials with pimozide in psychiatric practice. 3. Pimozide in the treatment of stress-induced psychic and functional disorders.
    Reyntjens AM
    Acta Psychiatr Belg; 1972 Nov; 72(6):671-6. PubMed ID: 4679635
    [No Abstract]   [Full Text] [Related]  

  • 17. [Correlation of the clinical and pharmaco-dynamic effects of Niamid in the treatment of severely mentally retarded children].
    Bettschart W; Broché JP; Tissot R
    Ann Paediatr; 1965; 205(3):216-33. PubMed ID: 4221631
    [No Abstract]   [Full Text] [Related]  

  • 18. A combination of anti-anxiety drugs: a report from the General Practitioner Research Group.
    Practitioner; 1975 Aug; 215(1286):230-3. PubMed ID: 1101248
    [No Abstract]   [Full Text] [Related]  

  • 19. [Trial of 1035 MD in a population of mentally retarded subjects in medico-pedagogic institutes].
    Besançon G; Blineau-Vecchierini MF
    Rev Neuropsychiatr Infant; 1973 Sep; 21(9):565-8. PubMed ID: 4586339
    [No Abstract]   [Full Text] [Related]  

  • 20. The effectiveness of methylphenidate hydrochloride (ritalin) on learning and behavior in public school educable mentally retarded children.
    Blacklidge VY; Ekblad RL
    Pediatrics; 1971 May; 47(5):923-6. PubMed ID: 4929903
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.